CLINICAL_TRIALS ClinicalTrials.gov record update

A Fourteen-week Placebo-controlled Dose-response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00148486
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:36.633404+00:00
Published At: 2013-10-29T00:00:00+00:00
Record Updated At: 2013-10-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Parkinson Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-10-29"
protocolSection.identificationModule.nctId: "NCT00148486"
protocolSection.identificationModule.officialTitle: "A Fourteen-week Placebo-controlled Dose-response Efficacy and Safety Study of NS 2330 in Early Parkinson\u0027s Disease Patients (Study for Proof of Concept in Early Parkinson\u0027s Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.